The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
5002269 6015164 F 1 5002269-1 20060502 20060512 EXP GXKR2006GB01386 SANDOZ INC., BROOMFIELD SITE 9 YR F N 38.2 KG 20060510 OT UNITED KINGDOM

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
5002269 1007286231 PS ERYTHROCIN STEARATE 1 ORAL 20 ML, ORAL Y D 64076
5002269 1007318820 SS AMOXICILLIN 1 ORAL 20 ML, ORAL Y D
5002269 1007318821 C ACETAMINOPHEN 1

Indications of drugs used

Event ID DRUG SEQ INDI PT
5002269 1007286231 LOWER RESPIRATORY TRACT INFECTION
5002269 1007318820 LOWER RESPIRATORY TRACT INFECTION

Outcome of event

Event ID OUTC COD
5002269 DS
5002269 HO

Reactions reported

Event ID PT
5002269 APHAGIA
5002269 CHAPPED LIPS
5002269 CONJUNCTIVITIS
5002269 HAEMATOCHEZIA
5002269 HAEMOPTYSIS
5002269 MELAENA
5002269 SWELLING FACE

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
5002269 FGN
5002269 HP
5002269 OTH

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
5002269 1007286231 20060127 20060127
5002269 1007318820 20060124 20060127